Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity.
Pospisilova M, Andrs M, Seifrtova M, Havelek R, Jun D, Tomsik P, Prchal L, Dolezal R, Tichy A, Kucera T, Korabecny J, Rezacova M.
Pospisilova M, et al.
Bioorg Chem. 2019 Feb;82:204-210. doi: 10.1016/j.bioorg.2018.10.001. Epub 2018 Oct 6.
Bioorg Chem. 2019.
PMID: 30326402